Titre : Thromboembolisme veineux

Thromboembolisme veineux : Questions médicales fréquentes

Termes MeSH sélectionnés :

Lymph Node Excision
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Thromboembolisme veineux : Questions médicales les plus fréquentes", "headline": "Thromboembolisme veineux : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Thromboembolisme veineux : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-07-21", "dateModified": "2025-04-17", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Thromboembolisme veineux" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Thromboembolie", "url": "https://questionsmedicales.fr/mesh/D013923", "about": { "@type": "MedicalCondition", "name": "Thromboembolie", "code": { "@type": "MedicalCode", "code": "D013923", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C14.907.355.590" } } }, "about": { "@type": "MedicalCondition", "name": "Thromboembolisme veineux", "alternateName": "Venous Thromboembolism", "code": { "@type": "MedicalCode", "code": "D054556", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "None None", "url": "https://questionsmedicales.fr/author/None%20None", "affiliation": { "@type": "Organization", "name": "" } }, { "@type": "Person", "name": "Jean M Connors", "url": "https://questionsmedicales.fr/author/Jean%20M%20Connors", "affiliation": { "@type": "Organization", "name": "Division of Hematology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA." } }, { "@type": "Person", "name": "Francis Couturaud", "url": "https://questionsmedicales.fr/author/Francis%20Couturaud", "affiliation": { "@type": "Organization", "name": "CHU Brest, Département de Médecine Interne et Pneumologie, Brest, France; Univ_Brest, INSERM U1304-GETBO, CIC INSERM 1412, F29609 Brest; FCRIN INNOVTE network, Saint-Etienne, France. Electronic address: francis.couturaud@chu-brest.fr." } }, { "@type": "Person", "name": "Susan R Kahn", "url": "https://questionsmedicales.fr/author/Susan%20R%20Kahn", "affiliation": { "@type": "Organization", "name": "Department of Medicine, McGill University, Montreal, QC, Canada; Division of Internal Medicine and Division of Clinical Epidemiology, Jewish General Hospital/Lady Davis Institute, Montreal, QC, Canada." } }, { "@type": "Person", "name": "Marc Blondon", "url": "https://questionsmedicales.fr/author/Marc%20Blondon", "affiliation": { "@type": "Organization", "name": "Service d'angiologie et d'hémostase, HUG, 1211 Genève 14, et Faculté de médecine, Université de Genève, 1211 Genève 4." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Characteristics of systematic lymph node dissection and influencing factors of sentinel lymph node biopsy using carbon nanoparticles in endometrial carcinoma: a single-center study.", "datePublished": "2023-02-07", "url": "https://questionsmedicales.fr/article/36750844", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12957-023-02922-0" } }, { "@type": "ScholarlyArticle", "name": "Pathological processing of sentinel lymph nodes in endometrial carcinoma - routine aspects of grossing, ultra-staging, and surgico-pathological parameters in a series of 833 lymph nodes.", "datePublished": "2022-07-19", "url": "https://questionsmedicales.fr/article/35854139", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s00428-022-03377-6" } }, { "@type": "ScholarlyArticle", "name": "Early experience of robotic axillary lymph node dissection in patients with node-positive breast cancer.", "datePublished": "2022-11-23", "url": "https://questionsmedicales.fr/article/36418519", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s10549-022-06760-8" } }, { "@type": "ScholarlyArticle", "name": "10-Year axillary recurrence in the RACS SNAC1 randomised trial of sentinel lymph node-based management versus routine axillary lymph node dissection.", "datePublished": "2023-06-23", "url": "https://questionsmedicales.fr/article/37393644", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.breast.2023.06.009" } }, { "@type": "ScholarlyArticle", "name": "Impact of Axillary Lymph Node Dissection and Sentinel Lymph Node Biopsy on Upper Limb Morbidity in Breast Cancer Patients: A Systematic Review and Meta-Analysis.", "datePublished": "2022-08-10", "url": "https://questionsmedicales.fr/article/35946806", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/SLA.0000000000005671" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Maladies cardiovasculaires", "item": "https://questionsmedicales.fr/mesh/D002318" }, { "@type": "ListItem", "position": 3, "name": "Maladies vasculaires", "item": "https://questionsmedicales.fr/mesh/D014652" }, { "@type": "ListItem", "position": 4, "name": "Embolie et thrombose", "item": "https://questionsmedicales.fr/mesh/D016769" }, { "@type": "ListItem", "position": 5, "name": "Thromboembolie", "item": "https://questionsmedicales.fr/mesh/D013923" }, { "@type": "ListItem", "position": 6, "name": "Thromboembolisme veineux", "item": "https://questionsmedicales.fr/mesh/D054556" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Thromboembolisme veineux - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Thromboembolisme veineux", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-18", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Thromboembolisme veineux", "description": "Comment diagnostiquer un thromboembolisme veineux ?\nQuels tests sont utilisés pour confirmer un TEV ?\nQuels signes cliniques indiquent un TEV ?\nLe scanner est-il utile pour le TEV ?\nComment évaluer le risque de TEV ?", "url": "https://questionsmedicales.fr/mesh/D054556?mesh_terms=Lymph+Node+Excision&page=6#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Thromboembolisme veineux", "description": "Quels sont les symptômes d'un TEV ?\nComment se manifeste une embolie pulmonaire ?\nLe TEV peut-il être asymptomatique ?\nQuels signes alertent sur un TEV ?\nLes symptômes varient-ils selon l'emplacement ?", "url": "https://questionsmedicales.fr/mesh/D054556?mesh_terms=Lymph+Node+Excision&page=6#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Thromboembolisme veineux", "description": "Comment prévenir le TEV ?\nLes bas de compression aident-ils ?\nQuand est-il crucial de prévenir le TEV ?\nLes voyages longs augmentent-ils le risque ?\nL'activité physique réduit-elle le risque ?", "url": "https://questionsmedicales.fr/mesh/D054556?mesh_terms=Lymph+Node+Excision&page=6#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Thromboembolisme veineux", "description": "Quels traitements sont disponibles pour le TEV ?\nComment fonctionnent les anticoagulants ?\nQuand utiliser la thrombolyse ?\nQuels sont les effets secondaires des anticoagulants ?\nLe traitement préventif est-il nécessaire ?", "url": "https://questionsmedicales.fr/mesh/D054556?mesh_terms=Lymph+Node+Excision&page=6#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Thromboembolisme veineux", "description": "Quelles sont les complications du TEV ?\nL'embolie pulmonaire est-elle grave ?\nQu'est-ce que le syndrome post-thrombotique ?\nLe TEV peut-il entraîner des problèmes cardiaques ?\nComment gérer les complications du TEV ?", "url": "https://questionsmedicales.fr/mesh/D054556?mesh_terms=Lymph+Node+Excision&page=6#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Thromboembolisme veineux", "description": "Quels sont les principaux facteurs de risque du TEV ?\nL'âge influence-t-il le risque de TEV ?\nLes femmes enceintes sont-elles à risque ?\nLes antécédents de TEV augmentent-ils le risque ?\nLe tabagisme est-il un facteur de risque ?", "url": "https://questionsmedicales.fr/mesh/D054556?mesh_terms=Lymph+Node+Excision&page=6#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer un thromboembolisme veineux ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur l'évaluation clinique, l'échographie Doppler et les tests sanguins." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour confirmer un TEV ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les tests incluent l'échographie, le D-dimère et parfois l'angiographie." } }, { "@type": "Question", "name": "Quels signes cliniques indiquent un TEV ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Les signes incluent douleur, œdème, rougeur et chaleur dans la zone affectée." } }, { "@type": "Question", "name": "Le scanner est-il utile pour le TEV ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le scanner thoracique peut détecter une embolie pulmonaire associée." } }, { "@type": "Question", "name": "Comment évaluer le risque de TEV ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Des scores comme le score de Wells aident à évaluer le risque de TEV." } }, { "@type": "Question", "name": "Quels sont les symptômes d'un TEV ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent douleur, gonflement, chaleur et rougeur dans la jambe." } }, { "@type": "Question", "name": "Comment se manifeste une embolie pulmonaire ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Elle se manifeste par une douleur thoracique, essoufflement et parfois toux avec sang." } }, { "@type": "Question", "name": "Le TEV peut-il être asymptomatique ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains cas de TEV peuvent ne présenter aucun symptôme visible." } }, { "@type": "Question", "name": "Quels signes alertent sur un TEV ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Un gonflement soudain d'une jambe et une douleur intense sont des signes d'alerte." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon l'emplacement ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes peuvent varier selon que le caillot est dans une veine profonde ou pulmonaire." } }, { "@type": "Question", "name": "Comment prévenir le TEV ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "La prévention inclut l'exercice régulier, l'hydratation et l'utilisation d'anticoagulants si nécessaire." } }, { "@type": "Question", "name": "Les bas de compression aident-ils ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les bas de compression aident à améliorer la circulation sanguine et à prévenir le TEV." } }, { "@type": "Question", "name": "Quand est-il crucial de prévenir le TEV ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Après une chirurgie ou lors d'une immobilisation prolongée, la prévention est cruciale." } }, { "@type": "Question", "name": "Les voyages longs augmentent-ils le risque ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les voyages prolongés en position assise augmentent le risque de TEV." } }, { "@type": "Question", "name": "L'activité physique réduit-elle le risque ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'activité physique régulière aide à réduire le risque de formation de caillots." } }, { "@type": "Question", "name": "Quels traitements sont disponibles pour le TEV ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent les anticoagulants, la thrombolyse et parfois la chirurgie." } }, { "@type": "Question", "name": "Comment fonctionnent les anticoagulants ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Ils empêchent la formation de nouveaux caillots et aident à dissoudre les existants." } }, { "@type": "Question", "name": "Quand utiliser la thrombolyse ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "La thrombolyse est utilisée dans les cas graves d'embolie pulmonaire pour dissoudre rapidement le caillot." } }, { "@type": "Question", "name": "Quels sont les effets secondaires des anticoagulants ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Les effets secondaires incluent des saignements, des ecchymoses et des réactions allergiques." } }, { "@type": "Question", "name": "Le traitement préventif est-il nécessaire ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, chez les patients à risque, un traitement préventif est souvent recommandé." } }, { "@type": "Question", "name": "Quelles sont les complications du TEV ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent l'embolie pulmonaire, l'insuffisance veineuse et le syndrome post-thrombotique." } }, { "@type": "Question", "name": "L'embolie pulmonaire est-elle grave ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'embolie pulmonaire peut être mortelle et nécessite une attention médicale immédiate." } }, { "@type": "Question", "name": "Qu'est-ce que le syndrome post-thrombotique ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "C'est une complication chronique du TEV, entraînant douleur et gonflement persistants." } }, { "@type": "Question", "name": "Le TEV peut-il entraîner des problèmes cardiaques ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une embolie pulmonaire peut provoquer des problèmes cardiaques en surchargeant le cœur." } }, { "@type": "Question", "name": "Comment gérer les complications du TEV ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "La gestion inclut un suivi médical régulier et des traitements adaptés aux complications." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque du TEV ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent l'immobilisation, l'obésité, les antécédents familiaux et certaines maladies." } }, { "@type": "Question", "name": "L'âge influence-t-il le risque de TEV ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le risque de TEV augmente avec l'âge, surtout après 60 ans." } }, { "@type": "Question", "name": "Les femmes enceintes sont-elles à risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la grossesse augmente le risque de TEV en raison des changements hormonaux et de la circulation." } }, { "@type": "Question", "name": "Les antécédents de TEV augmentent-ils le risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, avoir des antécédents de TEV augmente significativement le risque de récidive." } }, { "@type": "Question", "name": "Le tabagisme est-il un facteur de risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le tabagisme augmente le risque de formation de caillots sanguins." } } ] } ] }

Sources (7902 au total)

Characteristics of systematic lymph node dissection and influencing factors of sentinel lymph node biopsy using carbon nanoparticles in endometrial carcinoma: a single-center study.

Carbon nanoparticles (CNPs) are a new tracer for lymph node mapping, which can quickly reach and develop lymph nodes through a lymphatic network. This research investigated the characteristics of syst... We first applied CNPs to systematic lymph node dissection in 18 endometrial carcinoma patients as the study group and another 18 endometrial carcinoma patients who were not injected with anything serv... The average number of lymph nodes removed in the CNP-labeled study group was higher than that in the control group (p<0.001). CNPs improved the number of lymph nodes with a diameter ≤ 0.5cm. The detec... CNPs improve the detection rate of small lymph nodes. CNPs can trace sentinel lymph nodes in evaluating lymph node metastasis in endometrial carcinoma....

Pathological processing of sentinel lymph nodes in endometrial carcinoma - routine aspects of grossing, ultra-staging, and surgico-pathological parameters in a series of 833 lymph nodes.

Sentinel lymph nodes are widely accepted in the treatment of endometrial carcinoma. Whereas surgical aspects are well studied, the pathological work-up in terms of grossing, frozen section, and the so...

Early experience of robotic axillary lymph node dissection in patients with node-positive breast cancer.

Robotic surgical systems enable surgeons to perform precise movement in the surgical field using high-resolution 3D vision and flexible robotic instruments. We aimed to evaluate the feasibility and sa... Thirty-two women with breast cancer who underwent robot-assisted nipple-sparing mastectomy (RNSM) and level I/II axillary lymph node dissection were analyzed. Patients were divided into two groups: RN... The median age of the patients was 44 (range 20-59) years. Eleven patients underwent RALND. None of the clinicopathologic features differed between the two groups. There were no statistically signific... RALND can be safely performed in RNSM. RNSM with RALND is comparable to RNSM with CALND in terms of early surgical outcomes. The incision size can be reduced when using RALND....

10-Year axillary recurrence in the RACS SNAC1 randomised trial of sentinel lymph node-based management versus routine axillary lymph node dissection.

Sentinel node-based management (SNBM) is the international standard of care for early breast cancer that is clinically node-negative based on randomised trials comparing it with axillary lymph node di... 1.088 women with clinically node-negative, unifocal breast cancers 3 cm or less in diameter were randomly assigned to either SNBM with ALND if the sentinel node (SN) was positive, or to SN biopsy foll... First ARs were more frequent in those assigned SNBM rather than ALND (11 events, cumulative risk at 10-years 1·85%, 95% CI 0·95-3.27% versus 2 events, 0·37%, 95% CI 0·08-1·26%; HR 5·47, 95% CI 1·21-24... First ARs were more frequent with SNBM than ALND in women with small, unifocal breast cancers when all first axillary events were considered. We recommend that studies of axillary treatment should rep...

Impact of Axillary Lymph Node Dissection and Sentinel Lymph Node Biopsy on Upper Limb Morbidity in Breast Cancer Patients: A Systematic Review and Meta-Analysis.

To evaluate the impact of axillary lymph node dissection (ALND) and sentinel lymph node biopsy (SLNB) on upper limb (UL) morbidity in breast cancer patients.... Axillary de-escalation is motivated by a desire to reduce harm of ALND. Understanding the impact of axillary surgery and disparities in operative procedures on postoperative arm morbidity would better... Embase, MEDLINE, CINAHL, and PsychINFO were searched from 1990 until March 2020. Included studies were randomized-controlled and observational studies focusing on UL morbidities, in breast surgery pat... Sixty-seven studies were included. All studies reported a higher rate of lymphedema and pain after ALND compared with SLNB. The difference in lymphedema and pain prevalence between SLNB and ALND was 1... Prevalence of lymphedema after ALND was higher than previously estimated. ALND patients experienced greater rates of lymphedema, pain, reduced strength, and range of motion compared with SLNB. The fin...

Relevance of Subcarinal Lymph Node Dissection for Gastroesophageal Junction Adenocarcinoma.

Reported rates of subcarinal lymph node (LN) metastases for esophageal carcinoma vary from 20% to 25% and the relevance of subcarinal lymph node dissection (LND) for gastroesophageal junction (GEJ) ad... Patients with GEJ adenocarcinoma undergoing robotic minimally invasive esophagectomy from 2019 to 2021 were retrospectively assessed within a prospectively maintained database. Baseline characteristic... Among 53 consecutive patients, the median age was 62, 83.0% were male, and all had Siewert type I/II tumors (49.1% and 50.9%, respectively). Most patients (79.2%) received neoadjuvant therapy. Three p... In this consecutive series of patients with GEJ adenocarcinoma undergoing minimally invasive esophagectomy, subcarinal LN metastases were found only in patients with type I tumors and were noted in ju...

[Surgical technique of axillary, inguinal and iliac lymph node dissection].

Systematic lymph node dissection (SLND) plays an important role in the surgical treatment of many tumors. Despite continuous developments in surgical techniques, the morbidity in axillary, inguinal an... Description of the currently existing surgical techniques of axillary, inguinal and iliac SLND with presentation of the possible advantages and disadvantages, also with respect to the oncological resu... Based on the currently available literature reports, study results and own experience, the techniques of SLND and treatment results are presented.... SLND in the axillary, inguinal and iliac regions is still a challenging procedure for surgeons and patients. This problem exists due to the complex anatomy and the high morbidity. Modifications of ope... By using minimally invasive SLND in the axillary, inguinal and iliac regions, a significant reduction of wound complications can be achieved. Further prospective studies are needed to confirm the init...

Lymph node retrieval colon cancer: Are we making the grade?

Adequate lymph node (LN) excision is imperative for pathologic staging and determination of adjuvant treatment.... he 2004-2017 National Cancer Database (NCDB) was queried for curative colon cancer resections. Tumors were categorized by location: left, right, and transverse colon cancers. Adequate (12-20 LNs) vs. ... Of 101,551 patients, 11.2% (11,439) had inadequate lymphadenectomy. The inadequate lymphadenectomy rate steadily decreased. On multivariable analysis, inadequate LN retrieval was associated with trans... We are making the grade as NCDB data demonstrates a steady decrease in inadequate lymphadenectomy (2004-2017). There remain socioeconomic risk factors for inadequate lymphadenectomy that need to be ad...